Upadacitinib, a drug used to treat atopic dermatitis (AD), may potentially induce alopecia areata, a case study suggests.

Roivant's high valuation is justified, with a strong cash position, promising drug pipeline, and strategic partnerships ...

Atopic dermatitis or AD is a chronic ... Takayasu arteritis, systemic lupus erythematosus, and vitiligo. For More Such Health News, visit rttnews.com AbbVie NewsMORE Related Stocks Indices ...

Cellulitis looks like a rash, but is actually an infection of the middle layer of skin, says Dr. Yadav. It causes the skin to ...

Doctors evaluated her for depression, fibromyalgia (a condition that causes widespread pain), lupus (an autoimmune ... Autoimmune progesterone dermatitis is pretty rare. But if you've noticed ...

Shares of Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) have been given an average rating of “Hold” by the six brokerages that are currently covering the stock, Marketbeat Ratings reports. One ...

dermatitis herpetiformis, erythema multiforme (a reaction to the progesterone), lupus, or psoriasis (Rodenas et al., 1998). The diagnosis of APD requires a recurrent eruption related to menses and ...

Determining the percentage of subjects achieving an EASI 75 and a validated Investigator's Global Assessment for Atopic Dermatitis (vIGA ... systemic lupus erythematosus, and vitiligo.

Seeing a skin doctor isn’t just about checking for moles or getting a cream for acne or wrinkles. Dermatologists may see ...

Medscape Medical News, September 30, 2024 Kezar Life Sciences Pauses Trial for Lupus Treatment After Patient ... 2024 EADV 2024 Atopic Dermatitis Control on Biologic Persists Over 3 Years In ...

The drug – called brepocitinib – is the centrepiece of the new biotech's R&D pipeline and is already a pair of pivotal trials in patients with dermatomyositis and systemic lupus erythematosus ...

systemic lupus erythematosus, and vitiligo. AbbVie immunology global medical affairs vice-president Andrew Anisfeld said: “Despite taking steps to manage their condition, many patients with atopic ...